DNA Dilemma is a weeklong project in which NEWSWEEK's Mary Carmichael tries to figure out whether direct-to-consumer genetic tests are worth the money and effort. For more information on this subject, visit the following links:
More of Mary Carmichael's Writing on Direct-to-Consumer Genetic Tests
Breaking: FDA Likely to Require Premarket Clearance for DTC Personal Genomic Tests
Would Regulation Kill Genetic Testing?
Your Genetic Profile, Now Available in Aisle 10
Genetics Is Good Science, But Is It Good Business?
The World's Most Successful Failure
BLOGS BY CONTRIBUTORS
Genomes Unzipped a personal genomics group blog mostly by geneticists, including several who'll weigh in here.
More essays, articles, and resources
May We Scan Your Genome? (NEWSWEEK on the DTC phenomenon)
The New York Times's Pulitzer-winning series on genetic testing
The Personal Genetics Education Project
GeneTests.org, a database of available diagnostics
Letting the Genome Out of the Bottle, a New England Journal of Medicince commentary by our contributor Muin Khoury.
Natureon trouble in the personal-genomics industry.
The Boston Globe on DTC testing (featuring several project contributors)
EIGHT WHO GOT TESTED
Catherine Elton
Follow Mary on Twitter as she makes her decision, or add your opinion using the #DNADilemma hashtag.
DNA Dilemma: The Complete Series
Monday: Is Now the Time to Test?
Tuesday: What Can I Learn From This Test?
Wednesday: How Meaningful Are The Results?
Thursday: Should These Tests Be On the Market?
Friday: My Genome, Myself: I Make My Decision.
Recommended Reading: Further Articles, Essays, and Websites
DNA Dilemma FAQs: You're Doing What, Exactly?
Uncommon Knowledge
Newsweek is committed to challenging conventional wisdom and finding connections in the search for common ground.
Newsweek is committed to challenging conventional wisdom and finding connections in the search for common ground.
About the writer
To read how Newsweek uses AI as a newsroom tool, Click here.
